These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6376535)

  • 21. Use of randomly cloned DNA fragments for identification of Bacteroides thetaiotaomicron.
    Salyers AA; Lynn SP; Gardner JF
    J Bacteriol; 1983 Apr; 154(1):287-93. PubMed ID: 6833179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the RapID ANA system as a four-hour method for anaerobe identification.
    Downes J; Andrew JH
    Pathology; 1988 Jul; 20(3):256-9. PubMed ID: 3060822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species.
    Aldridge KE; Ashcraft D; Cambre K; Pierson CL; Jenkins SG; Rosenblatt JE
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1238-43. PubMed ID: 11257040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of broth microdilution susceptibility results for anaerobic organisms by use of a rapid direct colony inoculum.
    Mangels JI; Lindberg LH
    J Clin Microbiol; 1985 Feb; 21(2):269-72. PubMed ID: 3972999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery of anaerobic bacteria from vented blood-culture bottles.
    Martin WJ; Wilhelm PA; Bruckner D
    Rev Infect Dis; 1984; 6 Suppl 1():S59-61. PubMed ID: 6372038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting production of catalase by Bacteroides.
    Wilkins TD; Wagner DL; Veltri BJ; Gregory EM
    J Clin Microbiol; 1978 Nov; 8(5):553-7. PubMed ID: 730827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Bacteroides fragilis by indirect immunofluorescence.
    Weintraub A; Lindberg AA; Nord CE
    Med Microbiol Immunol; 1979; 167(4):223-30. PubMed ID: 94651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of cefmetazole against anaerobic bacteria.
    Cornick NA; Jacobus NV; Gorbach SL
    Antimicrob Agents Chemother; 1987 Dec; 31(12):2010-2. PubMed ID: 3481541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a direct fluorescent antibody staining method for rapid identification of members of the bacteroides fragilis group.
    DeGirolami PC; Mepani CP
    Am J Clin Pathol; 1981 Jul; 76(1):78-82. PubMed ID: 7020409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria.
    Martin DA; Sanders CV; Marier RL
    Antimicrob Agents Chemother; 1982 Jan; 21(1):168-9. PubMed ID: 6952818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.
    Goldstein EJ; Citron DM
    Antimicrob Agents Chemother; 1985 Feb; 27(2):162-6. PubMed ID: 3985600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recovery of Bacteroides fragilis group from clinical specimens following antimicrobial therapy.
    Brook I; Frazier EH
    Can J Microbiol; 1992 Mar; 38(3):226-9. PubMed ID: 1393825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tryptic soy bile-kanamycin test for the indentification of Bacteroides fragilis.
    Vargo V; Korzeniowski M; Spaulding EH
    Appl Microbiol; 1974 Mar; 27(3):480-3. PubMed ID: 4596383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora.
    Rafii F; Franklin W; Cerniglia CE
    Appl Environ Microbiol; 1990 Jul; 56(7):2146-51. PubMed ID: 2202258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic haemolysis test for presumptive identification and differentiation of Clostridium perfringens, C. bifermentans, C. sordellii, and C. paraperfringens.
    Gubash SM
    J Clin Pathol; 1980 Apr; 33(4):395-9. PubMed ID: 6249855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of feces by detection of Bacteroides genes.
    Nakanishi H; Shojo H; Ohmori T; Hara M; Takada A; Adachi N; Saito K
    Forensic Sci Int Genet; 2013 Jan; 7(1):176-9. PubMed ID: 23068949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
    Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
    Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid and correct identification of intestinal Bacteroides spp. with chromosomal DNA probes by whole-cell dot blot hybridization.
    Morotomi M; Ohno T; Mutai M
    Appl Environ Microbiol; 1988 May; 54(5):1158-62. PubMed ID: 3389810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry.
    Nagy E; Maier T; Urban E; Terhes G; Kostrzewa M;
    Clin Microbiol Infect; 2009 Aug; 15(8):796-802. PubMed ID: 19438622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bifidobacterium, Bacteroides, and Clostridium spp. in fecal samples from breast-fed and bottle-fed infants with and without iron supplement.
    Mevissen-Verhage EA; Marcelis JH; de Vos MN; Harmsen-van Amerongen WC; Verhoef J
    J Clin Microbiol; 1987 Feb; 25(2):285-9. PubMed ID: 3818925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.